Last reviewed · How we verify
NCT04918160: COVID-FREE
Evaluation of the Sanitary Safety of a Healthcare Professional Conference Held 9-11 June 2021 in Paris
trial testing Exposure to the FICS annual meeting (June 9-11 2021, Paris Congress Center) in Covid19 in 711 participants. Completed in 2 July 2021.
2 July 2021
Quick facts
| Lead sponsor | French Society for Intensive Care |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 711 |
| Start date | 8 June 2021 |
| Primary completion | 2 July 2021 |
| Estimated completion | 2 July 2021 |
| Sites | 1 location across France |
Drugs / interventions tested
- Exposure to the FICS annual meeting (June 9-11 2021, Paris Congress Center)
Conditions studied
- Covid19 — all drugs for Covid19 →
Sponsor
French Society for Intensive Care
Who can join
18 and older, any sex, with Covid19. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The COVID-SRLF study will evaluate the sanitary safety of the French Intensive Care Society (FICS) annual meeting held in Paris Congress Center from June 9th to June 11th 2021 in the Coronavirus Disease 2019 (COVID-2019) pandemic situation. The primary objective is to determine the proportion of attendees with a positive antigenic COVID-19 screening test at day 7 (+/- 1) of their participation to the meeting. This rate will be compared to a cohort of health care professionals (medical doctors and paramedical professionals) from the same hospital ward as the attendees but who did not attend the meeting (stratified on centers, gender, age (\< and \>= 40 years, vaccination status (0, 1 or 2 doses) and socio-professional status (medical doctor, nurse, nurse assistant).
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Sanitary safety of the 2021 French Intensive Care Society medical conference: a case/control study.
SRLF Trial Group. · · 2022 · cited 2× · PMID 35147794 · DOI 10.1186/s13613-022-00986-x
Verify or expand the search:
- PubMed search for NCT04918160
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Covid19
Currently open trials in the same condition.
- NCT03305341 — Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologic Mix · EARLY_PHASE1 · active not recruiting
- NCT06482138 — Dysfunction of Olfaction After COVID-19 Infection: Morphological and Histomolecular Investigation · NA · recruiting
- NCT04924803 — Community Developed Technology-Based Messaging to Increase COVID-19 Vaccine Uptake Among People Who Inject Drugs · NA · active not recruiting
- NCT05013632 — COVID-19 International Drug Pregnancy Registry · recruiting
- NCT04806061 — Urine Alkalinisation in COVID-19 · NA · active not recruiting
Other French Society for Intensive Care trials
Trials by the same sponsor.
- NCT06243094 — Antibiotic Therapy Practices for Ventilator-Associated Pneumonia (PETUNIA) · unknown
- NCT07176247 — Real-world Multicentre Study of AZtreonam-AVIbactam Treatment With Infections or Suspected Infections Caused by Multidru · enrolling by invitation
- NCT06455696 — Intra-Hospital Transport of Critically Ill Patients in Intensive Care Unit · recruiting
- NCT05775770 — Blood Glucose Management in Intensive Care Units · unknown
- NCT04304339 — Hypercapnic Acute Respiratory Failure in the ICU : the YETI Study · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04918160 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by French Society for Intensive Care
- Last refreshed: 21 October 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04918160.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing